FDA Guidance for Industry: Questions and Answers on Biosimilar Development and the BPCI Act

Titel:
FDA Guidance for Industry: Questions and Answers on Biosimilar Development and the BPCI Act
Herkunft/Verlag:

FDA

Inhalt:
This guidance document provides answers to common questions from prospective applicants and other interested parties regarding the Biologics Price Competition and Innovation Act of 2009 (BPCI Act).

Zurück

GMP Seminare nach Thema